Clinical Trial

Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging

Study acronym: MR-O-MICS
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to explore the integration of in vivo and ex vivo of MRI with histology and molecular assessments to advance non-invasive characterization of tumor heterogeneity in high-grade serous ovarian cance
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-10; most recent amendment 2025-02-11.
Status change: Not Yet Recruiting → Recruiting 2023-12-27
Trial Details
NCT Number NCT06084195
Lead Sponsor Institut du Cancer de Montpellier - Val d'Aurelle
Conditions High Grade Serous Ovarian Cancer
Enrollment 120 participants
Start Date 2023-12-19
Primary Completion 2026-10 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2025-02-12